Pharmaceutical Technology on MSN
FDA increases manufacturing flexibility for cell and gene therapies
Clinical and commercial quality controls are eased as the FDA looks to expedite therapy approvals in areas of unmet need.
New FDA communication introduces a more flexible, risk‑based chemistry, manufacturing, and controls (CMC) framework for cell and gene therapies, including phased data submission to support earlier ...
Citius Pharmaceuticals Inc. appointed drug industry veteran Kelly Creighton as executive vice president of chemistry, manufacturing and controls, the company announced Nov. 5. Creighton will be ...
The agency outlined the adjustments it's willing to make to "remove barriers and perceived misconceptions" for innovative medicines.
After the FDA issued a global recall last year of "sartan"-based drugs contaminated with a possible carcinogen, there's been plenty of blame to pass around. The most recent recipient of regulators' ...
In general, automating manufacturing leads to more efficiency, lower costs, higher throughput, less waste, higher labour productivity, and predictable lead times. Yet some process steps are a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback